Intravenous immunoglobulin (IVIG) is a type of medication used to treat people with immunodeficiencies, when the immune ...

After patients had undergone a 3-week run-in of subcutaneous darbepoetin alfa, they were randomized 1:1 to receive either subcutaneous or intravenous darbepoetin alfa once a week for 20 weeks ...

Objective: To characterize the pharmacokinetic-pharmacodynamic correlation of intranasal and intravenous fentanyl in opioid-naïve patients undergoing third molar extraction. Methods: A double ...

The FDA has approved a third biosimilar for tocilizumab, called Avtozma, the second such biosimilar to be available in both ...

In conclusion, we consider that the available data indicate that IVIg is not a lost cause for the therapy of MS 15,16, and that clinical trials are therefore warranted to determine if a ...

Among those with advanced gastric cancer, oral Liporaxel showed superior overall survival outcomes versus IV Liporaxel as a ...

In the beginning, the child commenced high-dose inhaled salbutamol therapy and, at the same time, an intravenous cannula was inserted into an antecubital vein. The purpose was to obtain a baseline ...

This medication is injected into a vein as directed by your doctor. The dosage and length of treatment are based on your medical condition and response to treatment. Children's dosage may also be ...

Approval was based on results from multiple studies, which demonstrated a slowing of cognitive decline in patients with ...

"We have been slow in finding solutions for preventing infections from intravenous catheters," said Althumayri. "A reason could be that we lack good platforms to test new catheter designs or ...

Avtozma, the third biosimilar to Actemra, has received FDA approval for multiple inflammatory diseases and COVID-19, ...

Manoj Jarange Patil’s health has reportedly begun to deteriorate, yet he remains resolute in refusing intravenous fluids, ...